Send mail to Author

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____     _____    ______      ___      _____    _    _   
 |__  //   |  ___|| |      \\   / _ \\   /  ___|| | || | || 
   / //    | ||__   |  --  //  | / \ || | // __   | || | || 
  / //__   | ||__   |  --  \\  | \_/ || | \\_\ || | \\_/ || 
 /_____||  |_____|| |______//   \___//   \____//   \____//  
 `-----`   `-----`  `------`    `---`     `---`     `---`
 


Back to frontdoor view

OPUS4 Logo